Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-08 5:09 pm Purchase | 13G | Y-MABS THERAPEUTICS INC YMAB | Paradigm Biocapital Advisors LP | 2,198,312 5.02% | 2,198,312 (New Position) | View |
| 2024-02-14 5:57 pm Purchase | 13G | ARCELLX INC ACLX | Paradigm Biocapital Advisors LP | 3,658,624 7% | 1,235,924 (+51.01%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | AMBRX BIOPHARMA INC AMAM | Paradigm Biocapital Advisors LP | 4,502,689 7.1% | 4,502,689 (New Position) | View |
| 2024-02-14 4:08 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Paradigm Biocapital Advisors LP | 3,176,743 5.5% | 859,109 (+37.07%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | AUTOLUS THERAPEUTICS PLC SPONS AUTL | Paradigm Biocapital Advisors LP | 12,611,335 7.2% | 2,512,751 (+24.88%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Paradigm Biocapital Advisors LP | 3,707,001 9.8% | 2,096,336 (+130.15%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | DISC MEDICINE INC IRON | Paradigm Biocapital Advisors LP | 2,385,857 9.9% | 1,149,939 (+93.04%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm Biocapital Advisors LP | 5,304,313 9.99% | 2,993,615 (+129.55%) | View |
| 2024-02-14 4:08 pm Sale | 13G | VOR BIOPHARMA INC.COM VOR | Paradigm Biocapital Advisors LP | 6,457,293 9.5% | -20,706 (-0.32%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | NUVALENT INC NUVL | Paradigm Biocapital Advisors LP | 3,858,008 6.7% | 478,928 (+14.17%) | View |
| 2024-02-14 4:08 pm Purchase | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm Biocapital Advisors LP | 7,903,600 14.3% | 100,000 (+1.28%) | View |
| 2024-02-14 4:08 pm Unchanged | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Paradigm Biocapital Advisors LP | 3,425,988 5.4% | 0 (Unchanged) | View |
| 2024-02-14 4:08 pm Sale | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm Biocapital Advisors LP | 0 0% | -399,658 (Position Closed) | View |
| 2024-02-05 4:21 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Paradigm Biocapital Advisors LP | 399,658 9% | 399,658 (New Position) | View |
| 2024-01-22 5:05 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm Biocapital Advisors LP | 1,927,506 5.8% | 1,927,506 (New Position) | View |
| 2024-01-02 5:20 pm Purchase | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Paradigm Biocapital Advisors LP | 3,425,988 5.4% | 3,425,988 (New Position) | View |
| 2023-10-30 5:12 pm Purchase | 13G | NUVALENT INC NUVL | Paradigm Biocapital Advisors LP | 3,379,080 5.9% | 3,379,080 (New Position) | View |
| 2023-09-25 5:24 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Paradigm Biocapital Advisors LP | 25,172,784 5.7% | 25,172,784 (New Position) | View |
| 2023-09-25 4:56 pm Purchase | 13G | DISC MEDICINE INC IRON | Paradigm Biocapital Advisors LP | 1,235,918 5.4% | 1,235,918 (New Position) | View |
| 2023-09-13 5:22 pm Purchase | 13G | OLEMA PHARMACEUTICALS INC OLMA | Paradigm Biocapital Advisors LP | 7,803,600 14.3% | 5,288,489 (+210.27%) | View |